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Abstract
Diacylglycerol kinase a (DGKa), by phosphorylating diacylglycerol into phosphatidic acid, provides a key signal driving cell
migration and matrix invasion. We previously demonstrated that in epithelial cells activation of DGKa activity promotes
cytoskeletal remodeling and matrix invasion by recruiting atypical PKC at ruffling sites and by promoting RCP-mediated
recycling of a5b1 integrin to the tip of pseudopods. In here we investigate the signaling pathway by which DGKa mediates
SDF-1a-induced matrix invasion of MDA-MB-231 invasive breast carcinoma cells. Indeed we showed that, following SDF-1a
stimulation, DGKa is activated and localized at cell protrusion, thus promoting their elongation and mediating SDF-1a
induced MMP-9 metalloproteinase secretion and matrix invasion. Phosphatidic acid generated by DGKa promotes
localization at cell protrusions of atypical PKCs which play an essential role downstream of DGKa by promoting Rac-
mediated protrusion elongation and localized recruitment of b1 integrin and MMP-9. We finally demonstrate that activation
of DGKa, atypical PKCs signaling and b1 integrin are all essential for MDA-MB-231 invasiveness. These data indicates the
existence of a SDF-1a induced DGKa - atypical PKC - b1 integrin signaling pathway, which is essential for matrix invasion of
carcinoma cells.
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Introduction
Most cancer-associated mortality is caused by metastatic
dissemination of primary tumors and the outgrowth of secondary
tumors at distant sites. Among the microenvironment signals
sustaining the invasive phenotype of cancer cells, stromal cell-
derived factor-1a (SDF-1a, also named CXCL12), plays a major
role in promoting cancer metastasis in several cancers, including
breast cancer [1]. SDF-1a is a chemokine secreted by tumor-
associated fibroblasts and bone marrow stromal cells, which
through activation of its CXCR4 receptor, promotes migration
and invasion of malignant cells and their homing to target organs
[2,3]. Indeed CXCR4 is a poor prognosis predictor in several
cancer types [4].
In breast cancer, the chemotactic and invasive activity of SDF-
1a/CXCR4 is mediated by both Ga13-mediated activation of
RhoA and Gai-mediated activation of Rac1 via DOCK180/
ELMO, which regulate cytoskeletal remodeling [5,6]. In myeloid
cells, Rac1 mediates SDF-1a-induced increase of integrin affinity,
while RhoA mediates formation of membrane protrusions and
CXCR4 trafficking to the cell surface in Rab11+ endosomes [7,8].
Moreover, in gastric cancer cells SDF-1a invasive and proliferative
activity is also stimulated by Gai- and PI3Kb-mediated activation
of mTOR complex 1, which contributes to Rac1 activation as well
[9]. Finally, atypical protein kinases C (PKCf and i, hereafter
aPKCs), which do not bind diacylglycerol (DG), play a key role in
mediating chemotaxis of bone marrow and muscle stem cells, and
of lymphocytes [10,11]. However neither the mechanisms by
which SDF-1a stimulates aPKCs nor their role in SDF-1a invasive
signaling in breast cancer cells have been elucidated.
DGKs are a multigenic family of ten enzymes phosphorylating
DG to generate phosphatidic acid (PA), thus reciprocally
regulating in a highly compartmentalized manner the concentra-
tion of both lipid second messengers and their signaling activities
[12]. Indeed, activation of DGKs results in the termination of DG-
mediated signals, while triggering PA-mediated ones. Increasing
evidence points to DGKa as a critical node in oncogenic signaling
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and as a putative novel therapeutic target in cancer: inhibition or
silencing of DGKa has been shown to reduce tumor growth and
mortality in glioblastoma and hepatic carcinoma xenograft models
[13,14]. Moreover, we recently showed that DGKa activity
sustains the pro-invasive activity of metastatic p53 mutations, by
promoting the recycling of a5b1 integrin to the tip of invasive
protrusions in tridimensional matrix [15]. DGKa is activated and
recruited to the membrane by growth factors, estrogen and
tyrosine kinase oncogenes through Src-mediated phosphorylation.
Upon growth factor stimulation, activation of DGKa mediates cell
migration, invasion and anchorage-independent growth [16–21].
Indeed, activation of DGKa is a central element of a novel lipid
signaling pathway involving PA-mediated recruitment at the
plasma membrane and activation of aPKCs in a complex with
RhoGDI and Rac1, thus providing a positional signal regulating
Rac1 activation and association to the membrane [22,23].
Altogether these data suggest that DGKa and aPKCs may act
as signaling nodes in the molecular crosstalk between soluble
chemotactic factors and the extracellular matrix, thus prompting
us to investigate the involvement of DGKa in cell migration and
invasion induced by SDF-1a in breast cancer cells. In here we
show that upon SDF-1a stimulation of breast cancer cells, DGKa
activity mediates aPKCs localization at protrusion sites and the
subsequent recruitment of b1 integrin and MMP-9 secretion.
Conversely over-expression of DGKa is sufficient to induce
aPKCs-dependent cell elongation. Finally, we observed that the
DGKa – aPKCs – b1 integrin pathway is an essential mediator of
chemokine-promoted cell migration and matrix invasion.
Materials and Methods
Cells Culture and Reagents
MDA-MB-231 cells were from ATCC, 293FT were from Life
Technologies. Cells were cultured in DMEM (Life Technologies)
with 10% FCS (LONZA) and antibiotics/antimycotics (Sigma-
Aldrich) in humidified atmosphere 5% CO2 at 37uC.
R59949 (Sigma-Aldrich) was dissolved in DMSO; equal
amounts of DMSO were used in the control samples. All reagents
are from Sigma-Aldrich apart: matrigel growth factor reduced (BD
Bioscences), human recombinant SDF-1a and HGF (Peprotech),
Myr-PKCf/i peptide inhibitor (BIOMOL) and NSC23766
(Tokris bioscience).
Antibodies: myc (clone 9E10 Santa Cruz), MMP-9 (2C3 Santa
Cruz for western blotting and immunofluorescence or IC9111F
RDsystems); PKCf/i (P0713 Sigma); b1 integrin (cat. 610467 BD
Transduction Laboratories for western blotting and immunoflu-
orescence or BV7 Abcam for cytofluorimetry); StrepMab-tag II (2-
1507-001 IBA); actin (C-2 Santa Cruz); tubulin (DM1A Sigma-
Aldrich); DGKa (Shaap et al., 1993), human RCP (rabbit in-house
Ab raised against RCP residues 379–649); Cdc42 (2462 Cell
signaling). Secondary antibodies HRP-mouse and HRP-rabbit
were from Perkin Elmer. Secondary antibodies anti-rabbit Ig
Alexa Flour-488 and anti-mouse Ig Alexa Flour-488 were from
Life Technologies as well as Alexa Flour 546-phalloidin, TO-
PRO-3 is from Life Technologies.
Invasion Assay
Invasion assay were performed in BD BioCoat Matrigel
Chambers. 50,000 cells/well were plated in the upper chamber
whereas SDF-1a (100 ng/ml) or 10% FCS were added to the
lower chamber in serum free medium. After 22 hours of
incubation in a humidified atmosphere 5% CO2 at 37uC, non
invading cells were removed from the upper surface of the
membrane and invading cells were fixed and stained with Diff-
Quik (Medion Diagnostic) before counting.
Wound Healing Assay
Cells were grown to confluence in 12 wells plates and the
monolayer wounded with a pipet tip. Cell debris were removed
and monolayer maintained in serum free medium for 24 hours
with or without HGF (50 ng/ml). The cells were stained with Diff-
Quik (Medion Diagnostic) and for each experimental point 8 fields
photographed (Axiovert inverted microscope with a 4x objective
and a digital camera). Cells migrating inside 2.3 mm of wound
were counted.
DGKa Activation Assay
Cells homogenates were prepared by collecting the cells with a
rubber scraper in buffer B (25 mM Hepes (pH 8), 10% glycerol,
150 mM NaCl, 5 mM EDTA, 2 mM EGTA, 1 mM ZnCl2,
50 mM ammonium molibdate, 10 mM NaF, 1 mM sodium
orthovanadate and Protease Inhibitor Cocktail), homogenizing
them with a 23 G syringe and by spinning at 500 g for 15 min.
Protein concentration was determined by the bicinchoninic acid
method (Pierce) and equalized for each point with buffer.
DGKa activity in cell homogenates (25 ml) was assayed by
measuring initial velocities (5 min at 30uC) in presence of
saturating substrates concentration (1 mg/ml diolein, 5 mM
ATP, 3 mCi/ml c32P-ATP (Perkin Elmer), 10 mM MgCl2,
1 mM ZnCl2, 1 mM EGTA in 25 mM Hepes pH 8, final
reaction volume 50 ml). Reaction was terminated with 0.1 M HCl
and lipids were extracted with cloroform methanol (1:1). PA was
separated by TLC in chloroform:methanol:water:25% ammonium
hydroxide (60:47:11:4). 32P-PA was identified by co-migration
with PA standards stained by incubation in iodine chamber.
Radioactive signals were detected and quantified by Molecular
Imager (Bio-Rad).
Immunofluorescence
Cells (30,000/well) were plated on matrigel coated coverlips in
24 wells cell culture plate and serum deprived for 16–24 hours
before stimulation. After stimulation cells were washed with PBS,
fixed in PBS containing 3% paraformaldehyde and 4% sucrose
and permeabilized in cold Hepes-Triton buffer (20 mM Hepes,
300 mM sucrose, 50 mM NaCl, 3 mM MgCl2, 0.5% Triton X-
100, pH 7.4). PBS containing 2% BSA was used as blocking
reagent for 15 minutes and as diluting agent for primary and
secondary antibodies (incubated for at least 1 hour). Intermediate
washing was performed with PBS containing 0.2% BSA.
Antibodies were added directly onto each glass coverslip in a
humidified chamber. Finally, each glass coverslip was washed
briefly in water and mounted onto a glass microscope slide using
Mowiol (20% Mowiol 4–88, 2.5% 1, 4-diazabicyclo [2.2.2] octane
in PBS, pH 7.4).
Confocal images were acquired with Leica confocal microscope
TCS SP2 using a 63x objective, NA = 1.32, equipped with LCS
Leica confocal software. Basal planes are shown. Each experi-
mental point was performed in duplicate. Depending on
preparation quality in each replicate roughly 30 images were
taken, containing between 70 and 100 cells.
Morphometry
For cell length analysis cells were plated in 24 wells plates and
phase contrast images of live cell were acquired with an Axiovert
inverted microscope equipped with a 40x objective and a digital
camera (Carl-Zeiss) and total cell length was measured with
DGKa/aPKCs/b1 Pathway in Matrix Invasion
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Image-Pro Plus software (MediaCybernetics). Alternatively in
Fig. 6D and Fig. S5B we used a 10x Plan Fluor objective, NA
0.3, and an inverted microscope (TE200; Nikon) with a digital
camera (CoolSNAP HQ; Photometrics) and Metamorph software
(Molecular Devices). For each experimental condition 5 random
fields were photographed containing more than 100 cells.
Cytofluorimetry
Cells were detached with ice could PBS 4 mM EDTA, fixed
with PBS containing 3% paraformaldehyde and stained as
indicated for 30 min. After washing with PBS containing 0.2%
BSA cells were analyzed with a FACScalibur instrument an
CellQuest software (BD) or Flowing software (Turku Bioimaging).
siRNA for Transient Silencing
Transient silencing was obtained by transfection of siRNA
(Sigma Genosys or Life Technologies). Briefly were plated on
matrigel coated coverlips to 30–50% confluence the day before
transfection and transfected using lipofectamine 2000 (Life
Technologies) according to manufacturer’s instructions. The day
after transfection cells were serum deprived for further 18 hours
before immunofluorescences or western blotting.
Figure 1. DGKa is necessary for SDF-1a-induced cell invasion. MDA-MB-231 cells were infected with lentiviral vectors expressing an inducible
shRNA against DGKa (shRNA-DGKa1) or an inducible control shRNA (shRNA-CTRL). Parental and infected cells were treated with 1 mg/ml doxycycline
for 72 hours to promote shRNA transcription. A) 50,000 cells were plated on matrigel invasion chamber and incubated for 24 hours in presence or in
absence of SDF-1a (100 ng/ml). Histogram reports mean 6 SE of fold over control values from 3 independent experiments with *t-test p,0.05, **t-
test p,0.01. B) The efficiency of DGKa down–regulation by shRNA was verified by quantitative RT-PCR. **t-test p,0.01. A) Cells were lysed and the
efficiency of DGKa down–regulation by shRNA was verified by western blot, tubulin was used as a loading control.
doi:10.1371/journal.pone.0097144.g001
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Validated siRNA DGKa [17] sense 59 GGAUGGCGA-
GAUGGCUAAAtt 39 antisense 59UUUAGCCAUCUCGC-
CAUCCgg 39.
siRNA PKCf sense 59CGUUCGACAUCAUCACCGAtt39an-
tisense 59UCGGUGAUGAUGUCGAACGgg39.
siRNA PKCi sense 59CGUUCGACAUCAUCACCGAtt39
antisense 59UCGGUGAUGAUGUCGAACGgg39.
siRNA b1 integrin sense 59GGAGGAAUGUUACACGGCU39
antisense 59 AGCCGUGUAACAUUCCUCCag 39.
Figure 2. SDF-1a stimulates DGKa activity and localization at protrusions site. A) MDA-MB-231 cells, stably expressing myc-DGKa, were
plated on matrigel-coated coverslips for 20 hours in FCS containing medium and cultured for further 20 hours in serum free medium. Cells were then
stimulated with 50 ng/ml of SDF-1a for the indicated times, fixed and stained for actin (red) and myc-DGKa (green). Representative images at 4 hours
after stimulation. Arrowheads indicate DGKa at protrusions. Histogram (B) reports the percentage of cells displaying myc-DGKa at protrusion as mean
6 SE of 5 independent experiments, *t-test p,0.05, **t-test p,0.005. Scale bar 24 mm. C) MDA-MB-231 cells were infected with a lentiviral vector
expressing inducible OST-tagged DGKa or an empty vector. To induce DGKa expression, cells were treated overnight with doxycycline (1 mg/ml) in
serum free medium. Cell were homogenized with buffer B in absence of detergent and analysed for DGK activity (upper panel). Values are mean6 SE
of 4 independent experiments with *t-test p,0.05. OST-DGKa and actin protein expression was verified by anti-OST and anti-actin western blot
(lower panel).
doi:10.1371/journal.pone.0097144.g002
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Figure 3. DGKa mediates SDF-1a-induced cell invasion by regulating aPKCs recruitment to cell pseudopods. A) MDA-MB-231 cells
were plated on matrigel-coated coverslips for 20 hours in FCS containing medium, transfected with CTRL or DGKa –specific siRNA and cultured for
further 20 hours in serum free medium. Cells were then stimulated for 6 hours with 50 ng/ml SDF-1a, fixed, and stained for actin (red) and aPKCs
(green). Arrowhead indicates aPKCs at protrusions. Scale bar 24 mm. B) Histogram reports the percentage of cells displaying aPKCs at protrusions as
mean 6 SE of 3 independent experiments with **t-test p,0.005, ***t-test p,0.0005. C) MDA-MB-231 cells were transfected with CTRL or DGKa –
DGKa/aPKCs/b1 Pathway in Matrix Invasion
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siRNA RCP: ON-TARGETplus RAB11FIP1 siRNA L-
015968-00-0005 (Dharmacon). Silencer negative control siRNA
AM4611 (Life Technologies) was used as negative control.
Generation of Tet-inducible Strep-tagged DGKa
Construct and Cell Infection
Human DGKa was amplified from pMT2- DGKa [24] by
PCR using the primers DGKa_ScII_fw (59-CCGCGGGCAG-
CATGGCCAAGGAGAGGGGC-39) and DGKa_H3_rv (59-
AAGCTTTTAGCTCAAGAAGCCAAA-39) and cloned into
pEXPR-IBA-105 (IBA GmbH) via SacII and HindIII to generate
pEXPR-Strep-DGKa. In a further step Strep-DGKa was
amplified by PCR using primers IBA_fw_N1 (59-GCGGCCGCA-
GACCCACCATGGCTAGC-39) and 105DGKa_MluI_rv (59-
ACGCGTTTAGCTCAAGAAGCCAAA-39) and cloned via NotI
and MluI to pLVX-Tight-Puro (Clontech). All constructs were
verified by DNA sequencing.
The resulting pLVX-Tight-PURO-OST-DGKa presents OST-
DGKa after a tetracycline controlled promoter and was used with
the Lenti-X Tet-On Advanced Inducible Expression System
(Clontec) according to manufacturer’s instruction. Lentiviral
particles were obtained in 293FT packaging cells co-transfected
with helper vectors. After double infection and selection we
obtained a polyclonal population of MDA-MB-231 cells express-
ing OST-DGKa in a tetracycline inducible manner. A control cell
line was also generated with an empty vector.
Generation of MDA-MB-231 Stably Expressing Myc-DGKa
Myc-DGKa was amplified from PMT2-myc-DGKa [16] by
PCR using the primers sense.
59CTCGAGACCAATGGAACAAAAGTTGATTTCAGAA-
GAAGATTTATTAATGGCCAAGGAGG39, antisense
59GCCCCTCTCCTTGGCCATTAATAAATCTTCTTCT-
GAAACAACTTTTGTTCCATGGCTCGAGTGCA39 and
cloned in the pDONOR211 vector using the Gateway system
(Life Technologies) according to manufacturer’s instructions. The
Gateway Technology (Life Technologies) was also used to
subclone myc-DGKa into pLenti4/V5-DEST lentiviral vector.
Lentiviral particles were obtained in 293FT packaging cells co-
transfected with helper vectors. After infection and selection we
obtained a polyclonal population of MDA-MB-231 cells constitu-
tively expressing myc-DGKa.
Inducible Silencing of DGKa in MDA-MB-231
We used the commercial pTRIPZ Inducible Lentiviral Human
DGKA shRNA Clone ID: V3THS_340705 (shRNA-DGKa1) or
pTRIPZ Inducible Lentiviral Non-silencing shRNA Control
RHS4743 (shRNA-CTRL). Those vectors express shRNA and
turboRFP under a doxycycline regulated promoter (Thermo
Scientific Open Biosystems). Lentiviral particles were obtained in
293FT packaging cells co-transfected with helper vectors. After
infection and selection we obtained a polyclonal population of
MDA-MB-231 cells which upon induction with doxycycline
(1 mg/ml, 72 hours) are 100% RFP positive.
Stable Silencing DGKa in MDA-MB-231
The shRNA for DGKa (forward: 59 GATCCCCGGTCAGT-
GATGTCCTAAAGTTCAAGAGACTTTAGGACATCACT-
GACCTTTTTGGAAA reverse: 59 AGCTTTTC-
CAAAAAGGTCAGTGATGTCCTAAAGTCTCTTGAACTT-
TAGGACATCACTGACCGGG) was cloned with H1-Promoter
within the lentiviral vector pCCL.sin.PPT.hPGK.GFPWpre [25].
The resulting vector co-express shRNA-DGKa and GFP (shRNA-
DGKa2). Empty vector was used as a control. Lentiviral particles
were obtained in 293FT packaging cells co-transfected with helper
vectors (Life Technologies). At 1 week after infection nearly 100%
of cells were GFP+.
Generation of ShRNA- b1 Integrin MDA-MB-231
ShRNA-b1integrin in pLKO were a kind gift of P. Defilippi
[26]. Lentiviral particles were generated with Sigma Mission
Lentivaral packaging mix according to manufacturer’s instruction
in 293FT cells and selected with puromycin. Empty pLKO was
used as a control.
Western Blotting
To verified protein down-regulation cells were lysed 48 hours
after transfection. Cell were washed with ice cold PBS, scraped on
ice in lysis buffer (25 mM Hepes, pH 8, 150 mMNaCl, 0.5/1%
Nonidet P-40, 5 mM EDTA, 2 mM EGTA, 1 mM ZnCl2,
50 mM NaF, 10% glycerol supplemented with fresh 1 mM
Na3VO4, and protease inhibitors) and clarified after centrifugation
of 15 minutes at 12000 rpm at 4uC. Samples were then
resuspended in Laemmli buffer, heat denatured, and separated
by SDS/PAGE. Proteins were then transferred on PVDF
membrane by using semi-dry system. Membrane was then blocked
with 5% BSA in PBS and incubated at 4uC overnight with
primary antibodies diluted in TBS tween 0.1%, BSA 2%, 0.01%
azide. After 4 washes with TBS-Tween 0.1%, membranes were
incubated with secondary antibodies and washed again. Western
blot were visualized using Western Lightning Chemiluminescence
Reagent Plus (Perkin Elmer).
Quantitative RT-PCR
RNA was extracted by TRI-Reagent Solution (Life Technol-
ogies) retrotrascribed with High-Capacity cDNA Reverse Tran-
scription Kits (Life Technologies) and cDNA quantified by real
time PCR using GUSB as normalizer. TaqMan gene expression
assays we from Life Technologies: b1 integrin (Hs 00559595),
GUSB (Hs 00939627), DGKa (Hs 00176278) and MMP-9 (Hs
00234579).
MMP-9 Secretion
MDA-MB-231 cells (250,000 cells/well) were plated in 6-well
cell culture plate and transfected with the indicated siRNA. After
24 hours in serum free media cells were treated with SDF-1a
(100 ng/ml in 500 ml serum-free medium). After 24 hours the
MMP-9 concentration in the supernatants was determined by
ELISA assay (Life Technologies).
specific siRNA and lysed. The efficiency of DGKa down–regulation by siRNA was verified at 48 hours after transfection by western blot, tubulin was
used as loading control. D) MDA-MB-231 cells were plated on matrigel-coated coverslips for 20 hours in FCS containing medium and cultured for
further 20 hours in serum free medium. Cells were then stimulated for 6 hours with 50 ng/ml SDF-1a, in presence or in absence of 1 mM R59949, fixed
and stained for actin (red) and aPKCs (green). Arrowheads indicate aPKCs at protrusions. Scale bar 24 mm. E) Histogram reports the percentage of cells
displaying aPKCs at protrusions as mean6 SE of 3 independent experiments with ***t-test p,0.0005. F) MDA-MB-231 cells (106/well) were plated on
matrigel invasion chamber and stimulates for 24 hours with SDF-1a (50 ng/ml) in presence or absence of PKCf pseudosubstrate (PS-PKCf, 10 mM).
Histogram reports mean 6 SE of folds over control values from 3 independent experiments with *t-test p,0.05.
doi:10.1371/journal.pone.0097144.g003
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Figure 4. DGKa and aPKCs mediate SDF-1a-induced recruitment of b1 integrin to pseudopods. A) MDA-MB-231 cells were plated on
matrigel-coated coverslips for 20 hours in FCS containing medium, transfected with CTRL or DGKa–specific siRNA and cultured for further 20 hours in
serum free medium. Cells were then stimulated for 6 hours with 50 ng/ml SDF-1a, fixed and stained for actin (red) and b1 integrin (green). Arrows
indicate b1 integrin at protrusions. Scale bar 24 mm. B) Histogram reports the percentage of cells displaying b1 integrin at protrusions as mean 6 SE
values of 3 independent experiments with **t-test p,0.005. C) MDA-MB-231 cells were plated on matrigel-coated coverslips for 20 hours in FCS
containing medium and cultured for further 20 hours in serum free medium. Cells were then stimulated for 6 hours with 50 ng/ml SDF-1a, in
presence or in absence of 1 mM R59949, fixed and stained for actin (red) and b1 integrin (green). Arrow indicates b1 integrin at protrusions. Scale bar
24 mm. D) Histogram reports the percentage of cells displaying b1 integrin at protrusions as mean 6 SE of 3 independent experiments with *t-test
p,0.05, **t-test p,0.005. E) MDA-MB-231 cells were plated on matrigel-coated coverslips for 20 hours in FCS containing medium, transfected with
CTRL or PKCf/i –specific siRNA and cultured for further 20 hours in serum free medium. Cells were then stimulated for 6 hours with 50 ng/ml SDF-1a,
fixed and stained for actin (red) and b1 integrin (green). Arrowheads indicate b1 integrin at protrusions. Scale bar 24 mm. F) Histogram reports the
percentage of cells displaying b1 integrin at protrusions as mean 6 SE of 3 independent experiments with **t-test p,0.005. G) MDA-MB-231 cells
DGKa/aPKCs/b1 Pathway in Matrix Invasion
PLOS ONE | www.plosone.org 7 June 2014 | Volume 9 | Issue 6 | e97144
Statistical Analysis
Data are shown as the mean 6 SEM. For statistical analysis,
Student’s t-test or ANOVA were used. Experiments shown are
representative at least 3 independent experiments.
Results
DGKa Is Necessary for SDF-1a-induced Cell Invasion
We previously showed that DGKa is necessary for matrix
invasion promoted by Epidermal Growth Factor (EGF) [15] or
Hepatocyte Growth Factor (HGF) in MDA-MB-231 breast
carcinoma cells [27]. In order to investigate the role of DGKa
in chemokine invasive signaling in breast cancer, we knocked
down DGKa in MDA-MB-231 using a lentiviral construct
expressing a DGKa-specific shRNA under an inducible promoter
(shRNA-DGKa1). This construct strongly downregulated DGKa
expression when compared with parental cells or a non-targeting
control sequence (shRNA-CTRL, Fig. 1 B and C). The invasive
ability of parental, DGKa-knocked down and control cells were
evaluated in a Matrigel invasion assay. SDF-1a (100 ng/ml)
doubles the number of parental as well as shRNA-CTRL MDA-
MB-231 invading across the matrigel insert (Fig. 1 A). Conversely,
shRNA-DGKa1 cells were unresponsive to SDF-1a stimulation.
We confirmed this finding with an independent shRNA (shRNA-
DGKa2) giving a comparable inhibition of SDF-1a stimulated
matrix invasion (Fig. S1), making off-target effects unlikely.
Those findings indicates that DGKa mediates the pro-invasive
signaling promoted not only by tyrosine kinase receptors [22] but
also by chemokine receptors involved in tumor cells metastatiza-
tion, such as those of SDF-1a.
SDF-1a Stimulates DGKa Activity and Localization at
Protrusions Sites
The previous findings that HGF, EGF and VEGF activate
DGKa and promote its recruitment to the plasma membrane in
epithelial and endothelial cells [15,17,22] suggest that SDF-1a
may promote localized DGKa activation at ruffling sites. Despite
its biological significance, the low level of DGKa expression in
MDA-MB-231 cells hampers activation and localization studies of
the endogenous protein with currently available antibodies.
Thus, for localization studies, MDA-MB-231 cells were stably
infected with a lentiviral vector expressing myc-DGKa and plated
on matrigel-coated coverslip to mimic the epithelial microenvi-
ronment. In unstimulated serum-deprived cells, myc–DGKa was
mainly cytoplasmic, with some cells displaying very little accumu-
lation at cell protrusions (Fig. 2A). Prolonged SDF-1a stimulation
(50 ng/ml; 4 to 6 hours) resulted in the localization of DGKa at
the tip of large protrusions (Fig. 2A and B). No detectable changes
were observed at earlier time points (15 minutes, Fig. 2B).
For enzymatic activation assays, we infected MDA-MB-231
with a lentiviral vector expressing OneStrep-Tagged DGKa
(OST-DGKa) under the control of a doxycycline-inducible
promoter. Upon 48 hours doxycycline treatment (1 mg/ml),
OST-DGKa was strongly overexpressed as compared to endog-
enous protein (Fig. S2A). Under these conditions the enzymatic
activity of OST-DGKa was responsible for almost the entire DGK
activity measured in cell homogenates. Both SDF-1a and HGF (a
well known DGKa activator) induced a further moderate increase
of OST-DGKa activity within 15 minutes of stimulation (Fig. 2C).
Altogether these data indicate that SDF-1a regulates DGKa
activity and localization and suggest that DGKa plays a role in the
formation and/or extension of cell protrusions induced by SDF-
1a.
DGKa Mediates SDF-1a-induced Cell Invasion by
Regulating aPKCs Recruitment to Cell Protrusions
DGKa, by producing PA, mediates aPKCs activation and
recruitment to the cell surface induced by growth factors [23,28].
Thus, we set to investigate whether DGKa mediates SDF-1a-
induced cell invasion by regulating aPKCs. To investigate the role
of DGKa in regulating aPKCs localization, MDA-MB-231 cells
were transiently transfected with control (siRNA-CTRL) or
DGKa-specific siRNA (siRNA-DGKa). Upon 48 hours from
transfection with siRNA-DGKa, the expression of DGKa was
nearly undetectable as compared to its expression in cells
transfected with control siRNA (Fig. 3C). Then, MDA-MB-231
cells were plated on matrigel-coated coverslips, serum starved and
stimulated with 50 ng/ml SDF-1a for 6 hours. In control siRNA
transfected cells, SDF-1a treatment significantly increased the
percentage of cells displaying aPKCs at protrusions, while DGKa
silencing strongly impaired aPKCs recruitment to the membrane
(Fig. 3A and B). In order to verify the requirement for DGKa
enzymatic activity, we carried out aPKCs localization assays in
presence or in absence of 1 mM R59949, a rather specific DGKa
inhibitor [16,29]. R59949 treatment completely abrogated aPKCs
localization at protrusions induced by SDF-1a, while it did not
affect aPKCs localization in unstimulated cells (Fig. 3D and E).
In order to investigate the role of aPKCs in SDF-1a-induced
invasion through extracellular matrix, MDA-MB-231 cells were
treated with 10 mM cell permeable PKCf pseudosubstrate (PS-
PKCf). In a matrigel invasion assay aPKCs inhibition significantly
reduced SDF-1a-induced invasion, while basal invasion was
unaffected in unstimulated cells (Fig. 3F).
Altogether, these data demonstrate that in SDF-1a-stimulated
breast carcinoma cells, localized activity of DGKa at pseudopodial
tips provides a crucial localization lipid signal for aPKCs
recruitment, thus mediating SDF-1a-induced invasive signaling.
DGKa and aPKCs Mediate SDF-1a-induced Recruitment
of b1 Integrin to Protrusions Sites
Recycling and clustering of b1 integrin at the tip of invasive
pseudopods is a key event sustaining the invasive properties of
malignant cells [30]. Conversely, growth factors stimulate invasion
both by inducing integrin clustering at actin-rich adhesive sites and
lamellipodia and by stimulating integrin recycling [26,31]. Thus,
we set to investigate whether the DGKa and aPKCs at protrusions
promote local accumulation of b1 integrin. In serum starved
MDA-MB-231 cells plated on matrigel-coated coverslips b1
integrin is mostly localized in intracellular vesicles in the
perinuclear/Golgi area. Upon SDF-1a stimulation, b1 integrin
also localized in clusters at the tip of cell protrusions (Fig. 4A, C
and E). However, either siRNA-mediated silencing of DGKa or
R59949-mediated inhibition of its enzymatic activity impaired
SDF-1a-induced localization of b1 integrin at cell extensions
were transfected with CTRL and PKCf/i –specific siRNA and lysed. The efficiency of PKCf/i down–regulation by siRNA was verified by western bloting,
tubulin was used as a loading control. H) MDA-MB-231 cells were infected with lentiviral vectors expressing a shRNA against b1-integrin (shRNA-b1)
or a control sequence (shRNA-CTRL). 50,000 cells were plated on matrigel invasion chamber and incubated for 24 hours in presence or in absence of
SDF-1a (100 ng/ml). Histogram reports mean 6 SE of fold over control values from 3 independent experiments with *t-test p,0.05, **t-test p,0.01.
I) The efficiency of b1-integrin down–regulation by shRNA was verified by quantitative RT-PCR.
doi:10.1371/journal.pone.0097144.g004
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Figure 5. DGKa and aPKCs mediates MMP-9 secretion and localization at protrusions. A) MDA-MB-231 cells were transfected with CTRL or
DGKa –specific siRNA and shifted to serum free media. After 24 hours cells were treated with 100 ng/ml SDF-1a in serum free medium for further 20
hours. MMP9 content in the supernatants was measured by ELISA assay, histogram reports secreted MMP-9 as mean 6 SE of 3 independent
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(Fig. 4A, B, C and D). Interestingly SDF-1a stimulation and
DGKa inhibition did not affect the expression of b1 integrin at the
cell surface, as measured by FACS analysis (Fig. S4A). Since
DGKa promotes Rac1 activation and membrane ruffles by
regulating aPKCs [15] and as DGKa mediates SDF-1a-induced
aPKCs recruitment to the membrane protrusions, we assessed
whether aPKCs controls b1 integrin localization. Indeed, siRNA-
mediated silencing of aPKCs (Fig. 4G) impaired SDF1-a-induced
localization of b1 integrin at cell protrusions (Fig. 4E and F).
Altogether these data suggest that SDF-1a, by activating the
DGKa/aPKCs pathway, stimulates the clustering of b1 integrin at
cell protrusions, rather than stimulating its bulk translocation at
the plasma membrane.
Since the expression of constitutively-membrane bound myr-
DGKa stimulates cell invasion by triggering RCP-mediated
recycling of integrin a5b1 [15], we set to investigate the role of
b1 integrin in SDF-1a-promoted cell invasion. To this purpose we
used shRNA mediated knockdown of b1 integrin which resulted in
an 80% reduction of its expression in MDA-MB-231 cells (Fig. 4I).
We found that, b1 integrin knock down severely impaired the
ability of MDA-MB-231 cells to invade through matrigel in
response to SDF-1a stimulation (Fig. 4H).
Altogether these data indicate that DGKa, by regulating
aPKCs, controls chemokine-induced b1 integrin localization at
protrusion sites in breast carcinoma cells, thus confirming the
pivotal role of b1 integrin in SDF-1a-promoted matrix invasion.
DGKa and aPKCs Mediate SDF-1a-induced MMP-
9 Secretion and Localization at Protrusions
Secretion of matrix metalloproteinases (MMPs) is involved in
the extracellular matrix degradation required for invasion of
cancer cells [32,33]. SDF-1a stimulates the secretion of MMP-9 in
several cancer cells, including MDA-MB-231 cells [34,35]. In
migrating cells, MMP-9 is addressed to the cellular extensions
involved in cell migration and accumulates at their tips [36]. Thus,
we investigated whether SDF1-a regulates intracellular localiza-
tion and secretion of MMP-9 through the DGKa/aPKCs axis.
MDA-MB-231 cells presented a low, constitutive secretion of
MMP-9 (40–80 pg/ml in the supernatant), which was not affected
by SDF-1a but was severely reduced by siRNA-mediated silencing
of DGKa (Fig. 5A). However, the mRNA levels of MMP-9 were
not affected by either SDF-1a stimulation or DGKa inhibition,
suggesting that this pathway does not regulate MMP-9 at the
transcriptional level in these cells (Fig. S4C). Conversely, SDF-1a
stimulated MMP-9 accumulation at protrusions of serum-starved
MDA-MB-231 plated on matrigel-coated coverslips (Fig. 5B to E).
We cannot rule out that MMP-9 staining may be associated to the
plasma membrane, indeed FACS analysis of these cells detected
low amounts of membrane-bound MMP-9 with a small increase in
MMP-9 surface positive cells following SDF-1a stimulation (Fig.
S4B). Silencing of DGKa impaired MMP-9 translocation induced
by SDF-1a, while it did not affect its localization in unstimulated
cells (Fig. 5B and C). Similarly, DGKa pharmacological inhibition
with R59949, completely impaired MMP-9 recruitment induced
by SDF-1a (Fig. 5D and E).
Altogether these data suggest that DGKa is essential for MMP-
9 accumulation at protrusions and subsequent release in the
extracellular space. Given the role of DGKa in regulating aPKCs,
we investigated whether aPKCs mediates SDF-1a-induced regu-
lation of MMP-9 localization. Indeed, siRNA-mediated silencing
of aPKCs blunted SDF-1a induced MMP-9 localization at
pseudopodial tips (Fig. 5F and G).
Altogether these data demonstrate that activation of the
DGKa/aPKCs pathway drives both MMP-9 and b1 integrin
localization at the pseudopodial tips, thus regulating the extension
of invasive protrusions and sustaining the invasive behavior of
MDA-MB-231 cells.
DGKa Overexpression Promotes aPKC/Rac Dependent
Cell Elongation
We observed that prolonged SDF1a treatment (6 hours, 50 ng/
ml) of matrigel plated MDA-MB-231 promotes the transition to an
elongated shape with the extension of long protrusions. Interest-
ingly both siRNA downregulation of DGKa and R59949-
mediated inhibition impairs this change in shape (Fig. S3A to C)
indicating the crucial requirement of DGKa activity.
Since the over-expression of membrane-bound myr-DGKa
stimulates cell migration in untransformed cells [18] and
pseudopod extension and invasion in A2780 ovarian cancer cells
[15], we investigated whether wild type DGKa over-expression
was sufficient to further stimulate invasion in MDA-MB-231 cells.
The previously described inducible OST-DGKa construct in
MDA-MB-231 cells allowed us to verify this issue as doxycycline
treatment induced a 30-fold increase in DGKa expression (Fig. 6A
and Fig. S2A), with an increase of about 300-fold of the enzymatic
activity (Fig. 2C). However, over-expression of OST-DGKa was
not sufficient to enhance migration of MDA-MB-231 in wound-
healing assay or to increase invasion through matrigel (Fig. S2B
and C). Nevertheless, over-expression of OST-DGKa led to
elongation of serum-starved MDA-MB-231 cells, while doxycy-
cline did not affect the cell length of empty vector-infected MDA-
MB-231 cells (Fig. 6B and D). Both in elongated and in shorter
cells, OST-DGKa is localized at the tip of cell protrusions (Fig. 6C)
suggesting that despite the absence of cytokines and growth factors
the strong up-regulation of DGKa activity is sufficient to recruit
the signaling machinery for membrane extension and to establish a
feed forward loop recruiting further DGKa.
Consistently, with the reported role of the aPKCs in mediating
DGKa-dependent Rac activation and membrane protrusions
[23], we observed that siRNA-mediated silencing of aPKCs
(Fig. 6G) blunted cell elongation induced by OST-DGKa over-
expression (Fig. 6E). Also the Rac inhibitor NSC23766 completely
experiments normalized for control, with *t-test p,0.05. B) MDA-MB-231 cells were plated on matrigel-coated coverslips for 20 hours in FCS
containing medium, transfected with CTRL or DGKa –specific siRNA and cultured for further 20 hours in serum free medium. Cells were stimulated for
6 hours with 50 ng/ml SDF-1a, fixed and stained for actin (red) and MMP-9 (green). Arrowhead indicates MMP-9 at protrusions. Scale bar 24 mm. C)
Histogram reports the percentage of cells displaying MMP-9 at protrusions as mean 6 SE of 3 independent experiments with ***t-test p,0.0005. D)
MDA-MB-231 cells were plated on matrigel-coated coverslips for 20 hours in FCS containing medium and cultured for further 20 hours serum free
medium. Cells were stimulated for 6 hours with 50 ng/ml SDF-1a, in presence or in absence of 1 mM R59949, fixed and stained for actin (red) and
MMP-9 (green). Arrowhead indicates MMP-9 at protrusions. Scale bar 24 mm. E) Histogram reports the percentage of cells displaying MMP-9 at
protrusions as mean 6 SE of 3 independent experiments with **t-test p,0.005, ***t-test p,0.01. F) MDA-MB-231 cells were plated on matrigel-
coated coverslips for 20 hours in FCS containing medium, transfected with CTRL or PKCf/i –specific siRNA and cultured for further 20 hours in serum
free medium. Cells were then stimulated for 6 hours with 50 ng/ml SDF-1a, fixed and stained for actin (red) and MMP-9 (green). Arrowhead indicates
MMP-9 at protrusions. Scale bar 24 mm. G) Histogram reports the percentage of cells displaying MMP-9 at protrusions as mean6 SE of 3 independent
experiments with *t-test p,0.05, **t-test p,0.005.
doi:10.1371/journal.pone.0097144.g005
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Figure 6. DGKa overexpression promotes a PKC-dependent cell elongation. MDA-MB-231 cells were infected with lentiviral vector
expressing inducible OST-tagged DGKa or an empty vector. To induce DGKa expression, cells were treated overnight with doxycycline (1 mg/ml) in
serum free medium. A) After cell lysis OST-DGKa induction was verified by western blotting with an antibody recognizing the OST-tag, while the
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blunted OST-DGKa induced elongation indicating the involve-
ment of Rac family GTPases (Fig. 6F). Those findings confirm the
relevance of aPKCs and Rac as DGKa downstream effectors
promoting cytoskeletal remodeling and extension of membrane
protrusions.
The expression of myr-DGKa drives pseudopodial extension by
stimulating RCP-mediated recycling of b1 integrin in A2780
carcinoma cells [15]. However, siRNA-mediated silencing of
either b1 integrin or RCP (Fig. S5C and D) did not affect
protrusion elongation induced by wild type DGKa in serum
starved MDA-MB-231 cells (Fig. S5A and B), suggesting that in
this experimental model b1 integrin and its RCP-mediated
recycling are not required for protrusion elongation.
These data indicate that up-regulation of DGKa activity by
SDF-1a is sufficient to promote the extension of membrane
protrusions through the aPKCs – RhoGDI – Rac pathway
[22,23], but that additional signaling pathways and/or its
localization at specific myrstyoilation-directed membrane com-
partment are required to trigger cells invasion.
Discussion
We and others established the relevance of DGKa activation
and membrane recruitment in growth factors signaling [37]. In
normal epithelia, endothelia and lymphocytes DGKa activity is
required to convey proliferative [17,38,39] and migratory [16–
18,22,23] signaling. Several studies pointed out DGKa involve-
ment in cancer showing that its activity is necessary in vivo for
glioblastoma and hepatocellular carcinoma progression [13], and
in vitro for proliferation and survival of endometrial carcinoma
[21], anaplastic large cell lymphoma [19], and melanoma [40].
Moreover, DGKa activity mediates matrix invasion sustained by
p53 pro-metastatic mutations in cancer cells [15]. However, the
molecular pathways by which DGKa controls carcinoma forma-
tion and metastatization are poorly known.
Inhere we investigated the role of DGKa in invasive signaling of
SDF-1a, one of the key signals driving metastasis [41], whose
receptor, CXCR4, is strongly associated to tumor growth and
spontaneous metastasis formation [1]. We used MDA-MB-231
cells, a highly invasive human breast cancer cell line, whose
invasiveness and tumorigenicity are dependent on the expression
of SDF-1a receptor, CXCR4 [42–44]. In these cells we had
previously shown that DGKa is required for EGF- [15] and HGF-
induced [27] migration in a tridimensional environment.
Interestingly, we show here that DGKa is also regulated by
SDF-1a, which stimulates its enzymatic activity and promotes its
recruitment at ruffling sites (Fig. 2). Moreover, we show that
activation of DGKa provides a key lipid signal required for SDF-
1a pro-invasive activity in MDA-MB-231 cells (Fig. 1).
We previously showed that the PA generated by HGF-induced
activation of DGKa recruits to the plasma membrane and
activates aPKCs in a complex with RhoGDI and Rac1, thus
mediating the release of Rac1 from RhoGDI, and its localization
and activation at ruffle sites [23]. The aPKCs subfamily comprises
the f and i isoforms, which are activated by PA [28] but insensitive
to DG.
Several pieces of evidence show that aPKCs and in particular
PKCi, play a key role in cancer cell invasion and tumor
progression [45]. Interestingly, PKCi is essential for K-Ras-driven
invasion in colon cancer by regulating Rac1 [46], while aPKCs
mediates EGF-induced cell migration of MDA-MB-231 breast
cancer cells [47]. Altogether these data further suggest that the
DGKa/aPKCs signaling axis contributes to pro-invasive signaling.
Accordingly, the finding that SDF-1a induces aPKCs localiza-
tion at protrusion sites through activation of DGKa, indicates that
the DGKa/aPKCs signaling axis mediates chemokine-driven
mammary carcinoma invasiveness (Fig. 3). DGKa-dependent
recruitment of aPKCs at protrusion is an essential signaling event,
since the silencing of either DGKa or aPKCs impairs downstream
events such as accumulation of b1 integrin and MMP-9 at the
plasma membrane (Fig. 4 and 5). The functional relevance of
aPKCs as a DGKa effector is further proved by the observation
that its silencing impairs DGKa-induced cell elongation (Fig. 6E)
and that its inhibition blocks SDF-1a-induced matrix invasion
(Fig. 3F).
The findings that aPKCs, RCP and b1 integrin are all required
for the invasiveness of MDA-MB-231 (Fig. 3F, 4H and ref. [15]),
and that upon SDF-1a stimulation b1 integrin is concentrated at
protrusion tips in a DGKa and aPKCs-dependent manner, are
consistent with our previous data showing that DGKa-generated
PA, through binding to RCP, docks a5b1 recycling vesicles to the
tips of invasive pseudopods. Altogether these findings suggest that
activation of aPKCs may also contribute to integrin recycling
induced by chemokines and growth factors, although there is no
experimental evidence for it.
Several pieces of evidence in different cell types indicate that
activation of aPKCs regulates MMPs production and secretion
[48]. For instance, PKCf activation mediates MMP-9 secretion
induced by SDF-1a in hematopoietic progenitors [11]. MMPs are
key players in the tumor microenvironment and play a major role
in invasion of extracellular matrix [49]. While some MMPs are
transmembrane proteins, most of them are soluble and bind to the
extracellular cell surface by interaction with several membrane
proteins, including b1 integrin and CD44v [50–54].
Our finding that both DGKa and aPKCs are required for SDF-
1a-induced release of MMP9 in the cell medium and for its
accumulation at protrusions, provides further strength to our thesis
that DGKa/aPKCs axis is a major component of chemokine pro-
invasive signaling. Interestingly, in SDF-1a-stimulated cells,
MMP-9 localization at cell surface superimposes with that of b1
integrin, suggesting that their function at protrusion tips is
coordinately regulated by activation of DGKa/aPKCs signaling.
extent of overexpression was verified with anti DGKa antibodies. Tubulin was used as loading control. B) Phase contrast images of control and OST-
DGKa cells cultured in presence or absence of doxycycline. Arrows indicate cells with long protrusions. Scale bar 50 mm. C) Confocal images of
doxycycline induced cells showing OST-DGKa localization, cells were stained for actin (red) and OST (green). Scale bar 24 mm. D) Time course of cell
elongation at 2, 10 and 18 hours with or without doxycycline treatment. Time lapse videos were recorded and total cell length measured. Box and
whiskers plots (black lines show median, whiskers: 5–95 percentile) of data from 3 independent experiments are shown, ***p,0.0001, 1 way ANOVA.
E) MDA-MB-231 cells expressing OST-DGKa were transiently transfected with control or PKCf/i-specific siRNA. After 48 hours DGKa expression was
induced by overnight treatment with doxycycline (1 mg/ml) in serum free medium. Images were acquired with a phase contrast microscope,
representative images are shown. Scale bar 50 mm. Total cell length was measured for at least 100 cells and reported as box and whiskers plot. F)
MDA-MB-231 cells expressing OST-DGKa were induced by overnight treatment with doxycycline (1 mg/ml) in serum free medium with or without
NSC23766 (100 mM). Images were acquired with a phase contrast microscope, representative images are shown. Scale bar 50 mm. Total cell length
was measured for at least 100 cells and reported as box and whiskers plot. MDA-MB-231 cells were transfected with CTRL and PKCf/i –specific siRNA
and lysed. The efficiency of PKCf/i down–regulation by siRNA was verified by western blotting, tubulin was used as a loading control.
doi:10.1371/journal.pone.0097144.g006
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Finally, the observation that DGKa over expression drives by
itself elongation of cell protrusions by regulating aPKCs is
consistent with active PKCf promoting wide cytoskeletal remod-
eling and protrusions in untrasformed cells [23]. The molecular
mechanisms by which aPKCs induces cell elongation downstream
to DGKa is still partially known. In line with our previous
demonstration that activation of the DGKa/aPKCs signaling
module stimulates the RhoGDI driven localization of both Rac1
and Cdc42 at membrane ruffles, we observed that the Rac
inhibitor NSC23766 blunts DGKa induced cell elongation
(Fig. 6G) and that SDF-1a-induced localization of Cdc42 at
protrusions of MDA-MB-231 cells is significantly reduced by
DGKa inhibition (Fig. S3D and E). Conversely, protrusion
extension occurs even in the absence of b1 integrin and RCP,
suggesting that DGKa-dependent activation of aPKCs regulates
cytoskeletal remodeling independently from b1 integrin recycling
and function, which are required, however, to enable cell
migration through a 3D matrix (Fig. 4H). While it is clear that
DGKa/aPKCs activity on cell elongation is independent on b1
integrin recycling, these data cannot rule out that accumulation of
b1 integrin and MMP-9 at protrusion tips depends on DGKa/
aPKCs-induced regulation of Rac1 or Cdc42 and cytoskeletal
contractility [31].
Altogether we showed that activation of the DGKa/aPKCs/b1
integrin pathway plays a key role in chemokine-driven matrix
invasion in breast cancer cells. Those observations suggest that
DGKa inhibition or silencing could be effective not only in
reducing primary tumor growth in vivo [13,14] but could
potentially also reduce the metastatic potential of carcinoma cells.
Supporting Information
Figure S1 DGKa is necessary for SDF-1a-induced cell
invasion. MDA-MB-231 cells were infected with lentiviral
vectors expressing a shRNA against DGKa (shRNA-DGKa2) or
an empty vector. A) Cells were lysed and the efficiency of DGKa
down–regulation by shRNA was verified by western blot, tubulin
was used as a loading control. B) 50,000 cells were plated on
matrigel invasion chamber and incubated for 24 hours in presence
or in absence of SDF-1a (100 ng/ml). Histogram reports mean 6
SE of fold over control values from 3 independent experiments
with *t-test p,0.05, ***t-test p,0.0005.
(TIF)
Figure S2 DGKa overexpression does not affect migra-
tion and invasion of MDA-MB-231 cells. MDA-MB-231
cells were infected with lentiviral vector expressing inducible OST-
tagged DGKa or an empty vector. To induce DGKa expression,
cells were treated overnight with doxycycline (1 mg/ml) in serum
free medium. A) After cell lysis, the extent of DGKa overexpres-
sion was verified with anti DGKa antibodies, long and short
exposures are shown. Actin was used as loading control. B) Cells
were grown to confluence in 12 well plates and subjected to a
wound healing assay for 24 hours in serum free medium. HGF
(50 ng/ml) was used as a positive control. The cells were stained
and those migrating inside 2.3 mm of wound counted. Histogram
reports mean 6 SE of fold over control values from 3 independent
experiments with *t-test p,0.05. C) 50,000 cells were plated on
matrigel invasion chamber and incubated for 24 hours in serum
free medium. Medium with 10% FCS was used as positive control.
Histogram reports mean 6 SE of fold over control values from 3
independent experiments with *t-test p,0.05.
(TIF)
Figure S3 DGKa is required for SDF-1a-induced pseu-
dopod elongation. A) MDA-MB-231 cells were plated on
matrigel-coated coverslips for 20 hours in FCS containing
medium, transfected with CTRL or DGKa -specific siRNA and
cultured for further 20 hours in serum free medium. Cells were
then stimulated for 6 hours with 50 ng/ml SDF-1a, fixed and
photographed at phase contrast. B) Histogram reports protrusions
length in mm as mean 6 SE values of 4 independent experiments
with *t-test p,0.005. C) MDA-MB-231 cells were plated on
matrigel-coated coverslips for 20 hours in FCS containing medium
and cultured for further 20 hours in serum free medium. Cells
were then stimulated for 6 hours with 50 ng/ml SDF-1a, in
presence or in absence of 1 mM R59949, fixed and photographed
at phase contrast. Histogram reports protrusions length in mm as
mean 6 SE of 3 independent experiments with *t-test p,0.005.
D) MDA-MB-231 cells were plated on matrigel-coated coverslips
for 20 hours in FCS containing medium and cultured for further
20 hours serum free medium. Cells were stimulated for 6 hours
with 50 ng/ml SDF-1a, in presence or in absence of 1 mM
R59949, fixed and stained for actin (red) and Cdc42 (green).
Arrowhead indicates Cdc42 at protrusions. Scale bar 24 mm. E)
Histogram reports the percentage of cells displaying Cdc42 at
protrusions as mean 6 SE of 3 independent experiments with *t-
test p,0.05.
(TIF)
Figure S4 SDF-1a is not affecting surface exposition of
b1-integrin and MMP-9. A) Surface expression of b1 integrin
was analyzed before (turquoise) and after (red) SDF-1a stimula-
tion. Flow cytometry histogram overlay comparing the level of b1
integrin expression before and after SDF-1a expression. Isotype-
matched controls mAb staining are given as dashed lines. MFI,
median fluorescence intensity. B) Surface expression of MMP-9
was analyzed before (turquoise) and after (red) SDF-1a stimula-
tion. Flow cytometry histogram overlay comparing the level of
MMP-9 expression before and after SDF-1a expression. Isotype-
matched controls mAb staining are given as dashed lines. MFI,
median fluorescence intensity. C) MDA-MB-231 cells were plated
on 6 wells dish for 20 hours in FCS containing medium and
cultured for further 20 hours serum free medium. Cells were
stimulated for 24 hours with 100 ng/ml SDF-1a, in presence or in
absence of 1 mM R59949. MMP-9 mRNA was quantified by
quantitative RT-PCR. Histogram reports the mean 6 SE of 3
independent experiments.
(TIF)
Figure S5 DGKa promoted cell elongation is indepen-
dent from b1 integrin and RCP. MDA-MB-231 cells were
infected with lentiviral vector expressing inducible OST-tagged
DGKa or an empty vector. A) Cells were transiently transfected
with control or b1 integrin-specific siRNA. After 48 hours DGKa
expression was induced by overnight treatment with doxycycline
(1 mg/ml) in serum free medium. Images were acquired with a
phase contrast microscope, representative images are shown. Scale
bar 50 mm. Total cell length was measured for at least 100 cells
and reported as box and whiskers plot. B) Cells were transiently
transfected with control or RCP-specific siRNA. After 48 hours
DGKa expression was induced by overnight treatment with
doxycycline (1 mg/ml) in serum free medium. Images were
acquired with a phase contrast microscope, representative images
are shown. Scale bar 50 mm. Total cell length was measured for at
least 100 cells and reported as box and whiskers plot. C) MDA-
MB-231 cells were transfected with CTRL and b1 integrin-specific
siRNA and lysed. The efficiency of b1 integrin down–regulation
by siRNA was verified by western blotting, tubulin was used as a
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loading control. D) MDA-MB-231 cells were transfected with
CTRL and RCP-specific siRNA and lysed. The efficiency of RCP
down–regulation by siRNA and of OST-DGKa induction was
verified by western blotting, actin was used as a loading control.
(TIF)
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